OKYO Pharma Ltd ADR (OKYO) — Cash Flow-to-Debt Ratio
OKYO Pharma Ltd ADR (OKYO) has a Cash Flow-to-Debt Ratio of -0.19x as of September 2025, meaning its operating cash flow of $-1.53 Million could theoretically repay 0% of its total liabilities ($8.06 Million) in one year. Check OKYO cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OKYO Pharma Ltd ADR Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for OKYO Pharma Ltd ADR across 18 annual periods. Also explore OKYO total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for OKYO Pharma Ltd ADR (2008–2025)
Year-by-year debt coverage analysis for OKYO Pharma Ltd ADR. For market capitalisation and broader financial context, see OKYO Pharma Ltd ADR stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.20x | $-1.81 Million | $9.23 Million | ▲ +84.7% |
| 2024 | -1.28x | $-9.49 Million | $7.42 Million | ▼ -20.6% |
| 2023 | -1.06x | $-7.70 Million | $7.26 Million | ▲ +73.8% |
| 2022 | -4.04x | $-5.47 Million | $1.35 Million | ▼ -347.4% |
| 2021 | -0.90x | $-1.60 Million | $1.77 Million | ▲ +44.6% |
| 2020 | -1.63x | $-1.20 Million | $737.20K | ▲ +65.0% |
| 2019 | -4.66x | $-1.99 Million | $426.72K | ▲ +73.4% |
| 2018 | -17.51x | $-1.59 Million | $91.06K | ▼ -595.9% |
| 2017 | -2.52x | $-651.27K | $258.76K | ▲ +29.9% |
| 2016 | -3.59x | $-650.88K | $181.34K | ▲ +61.7% |
| 2015 | -9.38x | $-1.42 Million | $151.07K | ▲ +32.6% |
| 2014 | -13.93x | $-3.45 Million | $247.95K | ▲ +33.2% |
| 2013 | -20.85x | $-3.82 Million | $183.32K | ▼ -271.7% |
| 2012 | -5.61x | $-4.67 Million | $832.89K | ▲ +66.3% |
| 2011 | -16.63x | $-1.31 Million | $78.74K | ▼ -51.2% |
| 2010 | -11.00x | $-878.61K | $79.87K | ▼ -317.7% |
| 2009 | -2.63x | $-226.35K | $85.96K | ▲ +25.8% |
| 2008 | -3.55x | $-513.95K | $144.86K | — |